Serum Gremlin-1 (sGREM1) concentrations were significantly higher in the STD and HFD groups (median: 8.7 ng/mL, 8.1–9.9, and median: 8.6 ng/mL, 7.0–9.9, respectively) than in the treatment groups. This evidence concerns the gene GREM1 and sexually transmitted disease.